Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax®) in children and adults

Vaccine

Volumn 15, Issue 1, 1997, Pages 61-64

  Krah, David L ^a   Cho, Iksung ^a   Schofield, Tim ^a   Ellis, Ronald W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

antibody assays; antibody responses to vaccine; varicella vaccine

Indexed keywords

CHICKENPOX VACCINE; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ADULT; AGE; ANTIBODY RESPONSE; ARTICLE; CHICKENPOX; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ASSAY; VARICELLA ZOSTER VIRUS; VIRUS NEUTRALIZATION;

ADULT; ANTIBODIES, VIRAL; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; NEUTRALIZATION TESTS;

EID: 0031020788     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00107-7     Document Type: Article

References (23)

1. 1 Preblud, S.R. Varicella: complications and cost. Pediatrics 1986, 78, 728-735
2. 2 Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., Yazaki, T. and Isomura, S. Live attenuated varicella vaccine used to prevent the spread of varicella in hospital. Lancet 1974, 2, 1288-1290
3. 3 Takahashi, M. Current status and prospects of live varicella vaccine. Vaccine 1992, 10, 1007-1014
4. 4 Ellis, R.W. Varicella vaccine. Vaccine 1995, 13, 1387-1388
5. 5 White, C.J., Kuter, B.J., Hildebrand, C.S. et al. Varicella vaccine (Varivax®) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991, 87, 604-610
6. 6 White, C.J., Kuter, B.J., Ngai, A. et al. Modified cases of chickenpox following varicella vaccination: correlation of protection with antibody response. Pediat. infect. Dis. J. 1992, 11, 19-23
7. 7 Wasmuth, E.H. and Miller, W.J. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J. med. Virol. 1990, 32, 189-193
8. 8 Keller, P.M., Neff, B.J. and Ellis, R.W. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J. Virol. 1984, 52, 293-297
9. 9 Kinchington, P.R., Ling, P., Pensiero, M., Moss, B., Ruyechan, W.T. and Hay, J. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J. Virol. 1990, 64, 4540-4548
10. 10 Vafai, A. and Yang, W. Neutralizing antibodies induced by recombinant virus expressing varicella-zoster virus gpIV. J. Virol. 1991, 65, 5593-5596
11. 11 Asano, Y. and Takahashi, M. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster. Biken J. 1978, 21, 15-23
12. 12 Krah, D.L., Provost, P.J. and Ellis, R.W. Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus. J. Virol. Meth. 1995, 53, 167-175
13. 13 Krah, D.L., Schofield, T.L. and Provost, P.J. Enhancement of varicella-zoster virus plaguing efficiency with an agarose overlay medium. J. Virol. Meth. 1990, 27, 319-326
14. 14 Provost, P.J., Krah, D.L., Kuter, B.J. et al. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 1991, 9, 111-116
15. 15 Kuter, B.J., Weibel, R.E., Guess, H.A. et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991, 9, 643-647
16. 16 Asano, Y., Albrecht, P., Vujcic, L.K., Quinnan, G.V., Kawakami, K. and Takahashi, M. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics 1983, 72, 291-294
17. 17 Asano, Y., Albrecht, P., Vujcic, L.K., Quinnan, G.V. and Takahashi, M. Evaluation of humoral immunity to varicellazoster virus by an enhanced neutralization test and by the fluorescent antibody to membrane antigen test. Arch. Virol. 1983, 75, 225-228
18. 18 Kino, Y. and Minamishima, Y. Diagnosis of zoster and evaluation of varicella vaccine with a passive hemagglutination assay. Vaccine 1993, 11, 1151-1153
19. 19 Ndume, P.M., Cradock-Watson, J. and Levinsky, R.J. Natural and artificial immunity to varicella zoster virus. J. med. Virol. 1988, 25, 171-178
20. 20 Steinberg, S.P. and Gershon, A.A. Measurement of antibodies to varicella-zoster virus by using a latex agglutination test. J. clin. Microbiol. 1991, 29, 1527-1529
21. 21 Nader, S., Bergen, R., Sharp, R. and Arvin, A.M. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J. infect. Dis. 1995, 171, 13-17
22. 22 Watson, B., Boardman, C., Laufer, D. et al. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin. Infect. Dis. 1995, 20, 316-319
23. 23 Keller, P.M., Lonergan, K., Neff, B.J., Morton, D.A. and Ellis, R.W. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies. J. Virol. Meth. 1986, 14, 177-188